Sam Brusco, Associate Editor11.16.23
BioIntelliSense, a continuous health monitoring and clinical intelligence company, began an in-hospital monitoring initiative with UC Davis Health that targets patients hospitalized for bone marrow transplant and hematology/oncology services.
The program will leverage BioIntelliSense’s BioButton wearable devices, algorithmic-based data analytics, and clinical intelligence system to monitor for subtle changes in vital sign trends and signs of potential patient deterioration.
“Our first priority is to provide the best care experience possible, which is even more critical when dealing with our most vulnerable patients, who are at risk for changes in condition,” Christine Williams, interim chief nursing and patient care services officer at UC Davis Health, told the press.
The BioButton device passively collects up to 1,440 sets of vital sign measurements per patient, per day. It’s applied to the upper left chest to securely capture high-frequency heart rate at rest, respiratory rate at rest, and skin temperature trending, along with other physiologic biometrics.
The clinically meaningful, statistically significant vital sign changes allow a display of contextual patient data and algorithmic-based notifications, BioIntelliSense explained.
“It’s an honor to partner with such an esteemed and innovative healthcare leader as UC Davis Health to advance the next standard of patient care fueled by medical grade and scalable tech-enabled solutions,” said BioIntelliSense founder and CEO James Mault, MD. “Smart care is the future of healthcare, and we are delivering on that promise with the introduction of this continuous care program at UC Davis Health.”
Earlier this year, the company also began a continuous patient monitoring initiative with Ardent Health Services and a partnership with Medically Home for home hospital care.
The program will leverage BioIntelliSense’s BioButton wearable devices, algorithmic-based data analytics, and clinical intelligence system to monitor for subtle changes in vital sign trends and signs of potential patient deterioration.
“Our first priority is to provide the best care experience possible, which is even more critical when dealing with our most vulnerable patients, who are at risk for changes in condition,” Christine Williams, interim chief nursing and patient care services officer at UC Davis Health, told the press.
The BioButton device passively collects up to 1,440 sets of vital sign measurements per patient, per day. It’s applied to the upper left chest to securely capture high-frequency heart rate at rest, respiratory rate at rest, and skin temperature trending, along with other physiologic biometrics.
The clinically meaningful, statistically significant vital sign changes allow a display of contextual patient data and algorithmic-based notifications, BioIntelliSense explained.
“It’s an honor to partner with such an esteemed and innovative healthcare leader as UC Davis Health to advance the next standard of patient care fueled by medical grade and scalable tech-enabled solutions,” said BioIntelliSense founder and CEO James Mault, MD. “Smart care is the future of healthcare, and we are delivering on that promise with the introduction of this continuous care program at UC Davis Health.”
Earlier this year, the company also began a continuous patient monitoring initiative with Ardent Health Services and a partnership with Medically Home for home hospital care.